Ketogenic therapy in serious mental illness: emerging evidence

This 2020 article provides us with a brief overview of preclinical and clinical evidence supporting the progress of ketogenic therapies in a variety of psychiatric disorders, especially in psychosis. This comes after Morris et al. (2020) published a review recognizing the exciting potential of the ketogenic diet and other ketogenic therapies in the treatment of serious mental disorders. This present article aims to further strengthen the case for induced ketosis in psychiatry. [NPID: psychiatric disorders, keto, ketogenic diet, psychosis]

Year: 2020

Reference: Sarnyai, Z., & Palmer, C. M. (2020). Ketogenic Therapy in Serious Mental Illness: Emerging Evidence. The international journal of neuropsychopharmacology, 23(7), 434–439. https://doi.org/10.1093/ijnp/pyaa036

Related Studies

Association between serum β-carotene and suicidal ideation in adults: a cross-sectional study

The study by Lv et al. (2024) aimed to determine if serum carotenoid levels are associated with suicidal thoughts and how depression may affect this relationship. This study involved 7,335 adults from the U.S. and used a cross-sectional design. High-performance liquid chromatography was used to assess the quantities of serum carotenoid components, such as lutein/zeaxanthin, […]

No impact of omega-3 fatty acid supplementation on symptoms or hostility among patients with schizophrenia

In this double-blind, placebo-controlled trial, Qiao et al. (2020) investigated the impact of administering fish oil (omega-3 fatty acids) supplements on the hostility and psychopathology among patients with acute violent schizophrenia. The participants were acute hospitalized patients showing violent behavior attributed to their schizophrenia, and who were being treated with antipsychotics. Thirty-two patients were given […]